Seroprevalence of SARS-CoV-2-Specific Antibodies, Faroe Islands
- PMID: 32726200
- PMCID: PMC7588539
- DOI: 10.3201/eid2611.202736
Seroprevalence of SARS-CoV-2-Specific Antibodies, Faroe Islands
Abstract
We conducted a nationwide study of the prevalence of severe acute respiratory syndrome coronavirus 2 infection in the Faroe Islands. Of 1,075 randomly selected participants, 6 (0.6%) tested seropositive for antibodies to the virus. Adjustment for test sensitivity and specificity yielded a 0.7% prevalence. Our findings will help us evaluate our public health response.
Keywords: 2019 novel coronavirus disease; COVID-19; Denmark; Faroe Islands; SARS-CoV-2; antibodies; coronavirus disease; respiratory diseases; seroprevalence; severe acute respiratory syndrome coronavirus 2; viruses; zoonoses.
Figures
References
-
- The Government of the Faroe Islands. Coronavirus in the Faroe Islands—statistics [cited 2020 Jun 6]. https://corona.fo/statistics
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous